VR Logo

Ind-Swift Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1986

Chairman: S R Mehta

Managing Director: Gopal Munjal

Group: --

Listing: NSE: INDSWFTLTD, BSE: 524652

Headquarters: Chandigarh, Punjab

Website: www.indswift.com

Key Facts

Market cap: R 11.92 Cr

Revenue (TTM): R 319.66 Cr

Earnings (TTM): R -0.42 Cr

Cash: R 19.72 Cr

Total Debt: R 1,009.90 Cr

Promoters' ownership: 55.55%

Liquidity: Moderate

52 Week range: R 1.90 - 6.00

Face value: R2.00

Shares outstanding: 5,41,64,653

10 Years Aggregate:

  • CFO: 124.18 Cr
  • EBITDA: -35.79 Cr
  • Net Profit: -925.39 Cr

Stock Performance

Time Period Ind-Swift S&P BSE Healthcare S&P BSE Small Cap
YTD-39.5120.33-13.46
1 month-14.046.8711.32
3 months-27.1414.23-12.77
1 Year-64.3021.43-20.39
3 Years-34.175.22-8.36
5 Years-14.410.311.78
10 Years-23.8111.353.21
As on 05-Jun-2020
Year Ind-Swift S&P BSE Small Cap S&P BSE Healthcare
2019-54.48-6.85-3.55
2018-37.17-23.41-5.89
2017100.8959.640.49
2016-5.081.77-12.88
2015-7.876.7615.06
2014-25.7769.2447.43
2013-39.46-11.2322.55

Review & Analysis